NRx Pharmaceuticals Inc. (NRXP) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    NRx Pharmaceuticals Inc.

    NASDAQ: NRXP · Real-Time Price · USD
    3.27
    -0.06 (-1.80%)
    At close: Oct 03, 2025, 3:59 PM
    3.30
    0.92%
    After-hours: Oct 03, 2025, 07:29 PM EDT

    NRx Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 1.44M 4.59M 20.05M 27.61M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 349K 431K 21K 15K
    Receivables
    		 n/a 6K 7K n/a
    Inventory
    		 n/a n/a -7K n/a
    Other Current Assets
    		 n/a n/a 5.73M n/a
    Total Current Assets
    		 3.3M 6.88M 25.8M 32.71M
    Property-Plant & Equipment
    		 n/a n/a n/a n/a
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 349K 431K 21K 15K
    Total Assets
    		 3.65M 7.32M 25.82M 32.73M
    Account Payables
    		 4.13M 4.63M 2.08M 3.69M
    Deferred Revenue
    		 n/a n/a n/a 2.84M
    Short-Term Debt
    		 1.57M 9.16M 7.7M 518K
    Other Current Liabilities
    		 10.93M 4.42M 5.81M 7.72M
    Total Current Liabilities
    		 21.86M 19.05M 16.59M 11.92M
    Long-Term Debt
    		 5.01M n/a 2.82M n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 5.01M n/a 1.82M n/a
    Total Liabilities
    		 26.87M 19.05M 18.41M 11.92M
    Total Debt
    		 6.58M 9.16M 10.53M 518K
    Book Value
    		 -23.22M -11.73M 7.41M 20.81M
    Book Value Per Share
    		 -2.21 -1.55 0.11 0.44
    Common Stock
    		 15K 84K 67K 59K
    Retained Earnings
    		 -278.27M -253.15M -223.06M -183.24M
    Comprehensive Income
    		 n/a -3K n/a n/a
    Shareholders Equity
    		 -23.22M -11.73M 7.41M 20.81M
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist